MarketBeat | Stock Market News & Analysis

Speakers argue NVIDIA's volatility creates opportunities in undervalued stocks Ashland, Central Garden, and HCA Healthcare.

29 min Listen to the original Episode page
NVIDIAValue InvestingActivist InvestorsConsumer StaplesHealthcareMarket VolatilityShort SqueezeETFs

Summary

Speaker_0 introduces the resignation of NVIDIA CEO Jensen Huang and discusses the potential market contagion from NVIDIA's weight in ETFs. Speaker_1 advocates for fundamental valuation over blind dip-buying, highlighting three specific stocks. Speaker_1 identifies Ashland (ASH) as a value play driven by activist investors and high short interest. Central Garden and Pet (CECE) is presented as a recession-resistant consumer staples company trading at a discount. HCA Healthcare (HCA) is described as a long-term winner benefiting from demographic trends and potential political tailwinds.

Key takeaways

  1. 1
    fund, every ETF owns NVIDIA as well as its competitors, where if it ends up being You know, kind of a a little bit of a contagion, uh, it could have a dramatic effect.

    Unidentified speaker (speaker_1) · 1:03

  2. 2
    A stock's valuation can appear reasonable (e.g., 17x forward earnings) even during a crisis if earnings growth expectations remain intact.

    Unidentified speaker (speaker_1) · 4:51

  3. 3
    seeing a a high short interest is kind of a double-edged sword. You want to be a little bit careful because again, the shorts tend to know what they're talking about. They tend to have good reasons for being short. On the other hand, when it goes against them, it can go against them in a big way and it can happen quickly.

    Unidentified speaker (speaker_1) · 12:47

  4. 4
    A Price-to-Sales ratio of 1.0 or less is considered a benchmark for cheap valuation in consumer staples sectors.

    Unidentified speaker (speaker_1) · 15:44

Episode sections

  1. 0:00 – 5:37

    NVIDIA CEO Resignation and Market Impact

    Speaker_0 introduces the resignation of NVIDIA CEO Jensen Huang and the resulting market volatility. Speaker_1 discusses the potential ripple effects on the broader market and ETFs, noting NVIDIA's significant weight in many portfolios.

  2. 5:37 – 8:47

    Valuation vs. Buying the Dip

    Speaker_0 and Speaker_1 debate the merits of buying dips versus analyzing valuation. Speaker_1 emphasizes using fundamentals and valuation metrics first, then using technical charts to time entries, rather than chasing price drops blindly.

  3. 8:47 – 15:05

    Stock 1: Ashland (ASH)

    Speaker_1 presents Ashland as a value play with activist investors pushing for strategic changes. He highlights its low PEG ratio, expected earnings growth, and potential for a short squeeze due to high short interest.

  4. 15:05 – 22:23

    Stock 2: Central Garden and Pet (CECE)

    Speaker_1 describes Central Garden and Pet as a recession-resistant consumer staples company trading at a discount. He notes its sideways price action for five years and potential breakout above $45, citing strong free cash flow and low valuation multiples.

  5. 22:23 – 28:52

    Stock 3: HCA Healthcare (HCA)

    Speaker_1 identifies HCA Healthcare as a long-term winner trading below its sector median valuation. He cites demographic trends, political tailwinds regarding healthcare policy, and strong historical performance as key factors.

Assets discussed

AssetKindStanceContext
NVIDIANVDAequityneutralMassive news from NVIDIA shaking the entire market today.
HCA Healthcare, Inc.HCAequityneutralright. So this one I would call somewhat recession proof, and that's HCA Healthcare, ticker symbol HCA.

“Stance” is how the speakers talked about the asset, not a recommendation.

Claims worth verifying

Jensen Huang resigned as CEO of NVIDIA, with the CFO taking over as interim CEO.

Unidentified speaker (speaker_0) ·2:03

How to verify: SEC Form 8-K filing from NVIDIA Corporation regarding executive changes. For recent events, verify 2026-08-12 through 2026-11-12. Use another period only when the speaker explicitly names it.

Primary source

NVIDIA stock is down about 30 percent from its highs.

Unidentified speaker (speaker_1) ·1:23

How to verify: Historical price data from financial data providers (e.g., Bloomberg, Yahoo Finance) for NVIDIA (NVDA) around the release date. For recent events, verify 2026-08-12 through 2026-11-12. Use another period only when the speaker explicitly names it.

Primary source

NVIDIA is trading at about 17 times 2027 projected earnings.

Unidentified speaker (speaker_1) ·4:51

How to verify: Consensus analyst estimates for NVIDIA's 2027 EPS available via financial data platforms (e.g., FactSet, Bloomberg) compared to current stock price. For recent events, verify 2026-08-12 through 2026-11-12. Use another period only when the speaker explicitly names it.

Primary source

Ashland (ASH) is expected to grow earnings 28 percent this fiscal year ending September 2027.

Unidentified speaker (speaker_1) ·9:07

How to verify: Ashland Corporation's earnings guidance and consensus analyst estimates for fiscal year 2027. For recent events, verify 2026-08-12 through 2026-11-12. Use another period only when the speaker explicitly names it.

Primary source

Ashland is trading at 18 times 2027 earnings.

Unidentified speaker (speaker_1) ·9:27

How to verify: Current Ashland stock price divided by consensus 2026 EPS estimates. For recent events, verify 2026-08-12 through 2026-11-12. Use another period only when the speaker explicitly names it.

Selenys sold its materials business for 13 times EBITDA.

Unidentified speaker (speaker_1) ·10:18

How to verify: Press releases or SEC filings related to Selenys' divestiture transaction details. For recent events, verify 2026-08-12 through 2026-11-12. Use another period only when the speaker explicitly names it.

Primary source

Ashland stock is currently at $76.

Unidentified speaker (speaker_1) ·10:38

How to verify: Real-time or historical stock price data for Ashland (ASH) on the trading day of the podcast. For recent events, verify 2026-08-12 through 2026-11-12. Use another period only when the speaker explicitly names it.

11 percent of Ashland's float is sold short.

Unidentified speaker (speaker_1) ·11:46

How to verify: Short interest data for Ashland (ASH) from FINRA or broker-dealer reports. For recent events, verify 2026-08-12 through 2026-11-12. Use another period only when the speaker explicitly names it.

Central Garden and Pet (CECE) has a $2.6 billion market cap.

Unidentified speaker (speaker_1) ·15:25

How to verify: Market capitalization data for Central Garden and Pet (CECE) on the trading day of the podcast. For recent events, verify 2026-08-12 through 2026-11-12. Use another period only when the speaker explicitly names it.

HCA Healthcare is trading at a 17 PE ratio, below the sector median of 20.

Unidentified speaker (speaker_1) ·23:17

How to verify: HCA Healthcare's current stock price divided by trailing or forward EPS, compared to the median PE of the Healthcare sector (e.g., S&P 500 Healthcare Index). For recent events, verify 2026-08-12 through 2026-11-12. Use another period only when the speaker explicitly names it.

Do your own research

  • Verify NVIDIA CEO Jensen Huang's resignation status via NVIDIA's official investor relations page or SEC filings.
  • Check Ashland's (ASH) current short interest percentage and activist investor holdings via Bloomberg or Yahoo Finance.
  • Review Central Garden and Pet's (CECE) Price-to-Sales ratio and free cash flow statements in its latest 10-K or 10-Q.
  • Analyze HCA Healthcare's (HCA) valuation multiples relative to sector peers using financial data providers like Morningstar or YCharts.
  • Research potential legislative impacts of Democratic control on healthcare valuations via Congressional budget office reports or healthcare policy analysis.
  • Confirm Ashland's PEG ratio and earnings growth estimates from consensus analyst forecasts.
  • Assess Central Garden and Pet's historical price action around the $45 resistance level using charting tools.
  • Evaluate HCA Healthcare's exposure to Medicare/Medicaid policy changes through its regulatory risk disclosures in SEC filings.
Full transcriptexpand
0:00
Unidentified speaker (speaker_0): Massive news from NVIDIA shaking the entire market today. Should you be chasing this dip or is there a better way to find value in the market? Joining us today is Mark Lichtenfeld with the Oxford Club with a look at three stocks where you can find true value in this market today. Mark, I'm excited to dive into those stocks and really talk a little
0:20
Unidentified speaker (speaker_0): bit more about your theory on investing and what it means to find cheap stocks, stocks that are actually on sale, the real bargains in the market right now.
0:27
Unidentified speaker (speaker_0): But we can't start this video without talking about what's happening with NVIDIA today. Wild news uh shaking the entire market. Let's just talk about the ripple effects that you expect to see, not just for NVIDIA, but for the rest of the market today too.
0:42
Unidentified speaker (speaker_1): Sure. So you know, as you and I are speaking Are right now, the stock is is bouncing a little bit. But if the stock is not able to really find its footing, if investors decide to continue to sell the stock, as you said, it would have a huge ripple effect on the market. I mean, think about it, every
1:03
Unidentified speaker (speaker_1): fund, every ETF owns NVIDIA as well as its competitors, where if it ends up being You know, kind of a a little bit of a contagion, uh, it could have a dramatic effect. I'm not trying to cause any panic, because so far. the damage has been contained pretty much just to NVIDIA stock, and even not too terrible, uh just you know, given today
1:23
Unidentified speaker (speaker_1): as as you and I are speaking. I mean, obviously the stock is down about 30 percent from its highs, even before all this news broke, uh, it had been tumbling. But um it has potential to really affect a lot of people in a in a negative way, or uh if the stock is able to bounce, if people just say, hey, this is an isolated incident,
1:43
Unidentified speaker (speaker_1): the company's going to move on, their earnings are still going to grow significantly. It's still arguably the most important company, then everything could just go back to normal and NVIDIA could continue to rise and hit new highs eventually. And you know, all will be forgiven, perhaps not for uh the CEO, but at least for the company.
2:03
Unidentified speaker (speaker_0): Yeah. And just to say the headline today, if you've missed it somehow, uh Jensen Wong resigned as the CEO of NVIDIA. The CFO is going to be taking over as the interim CEO of the company. And they are going to continue reporting earnings on Tuesday as expected. So I think there's going gonna to be a lot of weight on
2:23
Unidentified speaker (speaker_0): that as well. I think there's more potential for volatility in the market on Tuesday. with whatever comes out of these earnings reports, too. And so uh all of that to say, buckle in. It seems like there's gonna be a little bit more volatility coming very soon, Mark. And I think a lot of investors look at the volatility um, and maybe for for good reason as a chance to buy the dip on
2:43
Unidentified speaker (speaker_0): some of these massive companies, a chance to find some value and get some higher returns when you see the market in a little bit of turmoil like it is right now. after such huge news on one of the country's biggest stocks. So for you, are you one who chases those dips, who looks to find value in an NVIDIA when you see uh an
3:03
Unidentified speaker (speaker_0): isolated insulin like this taking the company stock down so much?
3:06
Unidentified speaker (speaker_1): This that's a great question. So every situation is obviously different and it depends why a stock is falling. Many times there's a very good reason that investors are selling. off a stock because it deserves to be, whether it's because earnings are slowing, uh mismanagement, you know, you name it, there can be a variety of factors that cause a stock to fall for very
3:26
Unidentified speaker (speaker_1): good reason. With NVIDIA, you know, I think it's it's kind of a mix where you had this
3:33
Unidentified speaker (speaker_1): CEO who was a visionary, founder of the company. Obviously, you know, he was kind of like a steel. Steve Jobs, you know, mythical character who led this company. And he obviously was incredibly important to NVIDIA's growth. So with his departure, there's certainly a bit of an unknown. And as
3:53
Unidentified speaker (speaker_1): you mentioned, the CEFO is going to be the interim CEO. They have said that they're going gonna to look for a new CEO. So we don't know who is going to be managing this company long term. On the other hand, NVIDIA
4:03
Unidentified speaker (speaker_1): does have its hands in so much technology, so much of the AI movement and growth. And their earnings are expected to continue to grow very strongly, very significantly. Is this interim CFO, is the is a potential new CEO going to completely derail that? Probably
4:23
Unidentified speaker (speaker_1): not. You know, obviously there's going to be some changes with new management, but I think the long-term story is still pretty intact with NVIDIA, at least right now. Again, it's hard to imagine new management coming in and completely disrupting the story. So to me, you
4:43
Unidentified speaker (speaker_1): know, is it a buying opportunity at this moment? Might want to see where the stock settles, if it continues to be volatile.
4:51
Unidentified speaker (speaker_1): but with strong earnings growth and a pretty reasonable valuation. I mean, right now the stock is trading at about 17 times 2027 projected earnings. That is a pretty reasonable valuation for a company. Forget the name NVIDIA for a company with this kind of growth and this kind
5:11
Unidentified speaker (speaker_1): of um importance in its market. markets. I think 17 times earnings uh is is a pretty reasonable number. And I think at least with 2027, you can have, you know, some level of confidence that they're going to be in the ballpark of of their earnings estimate. I mean, every company there's there's always, you know, a
5:31
Unidentified speaker (speaker_1): chance that you could miss, a chance you could beat. But you know, I I I think it's a it's reasonable to expect that they'll be in the ballpark. Trevor
5:37
Unidentified speaker (UNKNOWN): Burrus
5:37
Unidentified speaker (speaker_0): Yeah. It's a good analysis. of what's happening with NVIDIA, but you you keyed in on a word that I want to focus on. And I know that's what we're going to talk about with the stocks that you have for us today too, and that's valuation. And and talking about we again, we have so many videos that come out all of the time that say buy the dip, buy the dip. And we hear from a lot of uh technical analysts on the show who are just looking at charts and they're looking
5:57
Unidentified speaker (speaker_0): at what has something pulled back to, where is that bounce happening? That is one way to invest. It's one way to look at the market for sure. But I want to address looking at the valuation versus looking at, oh, the stock is down 70% off its highs. Why is that an important differentiator for you, Mark?
6:14
Unidentified speaker (speaker_1): And anytime you're looking at a stock that has fallen, like I said, you know, sometimes there's a very good reason. So you want to understand that. I do find that the technical levels can be very important and good places to perhaps take a scroll. swing. So if you're looking at a stock, it's falling, you say to yourself, okay, this is a reasonable valuation or low valuation, you know, I think
6:34
Unidentified speaker (speaker_1): this is something I want to get involved in. You may want to wait until it falls down to support, improve the risk-to-reward situation. Or on the flip side, and I'll be talking about this with one of the stocks today, when it actually breaks out. Very often a stock can be a really good value. valuation, but kind of be dead money for months or even
6:54
Unidentified speaker (speaker_1): years just trading sideways. So once it breaks out of resistance, that could be the signal, okay, now you have the company with good fundamentals, low valuation, but now the market's starting to notice and the stock looks like it's going to be on the move. So you know, every situation can be a little bit different. And and when stocks are falling hard and I'm I'm starting to get interested,
7:14
Unidentified speaker (speaker_1): you I
7:14
Unidentified speaker (UNKNOWN): know,
7:14
Unidentified speaker (speaker_1): I'm looking at first the business. You know, is is the business solid? Are they going to grow? Do they have cash flow? Uh that all that's really important. Then the valuation, and then I'll look at a chart and say, okay, is this the t time to buy? Is it am I trying to catch a falling knife here? Or is there you know some level of support or like I said, perhaps getting ready to break out?
7:34
Unidentified speaker (speaker_1): Where Right I can and fine-tune that timing. So, you know, like the fundamental story, like the valuation, and then you use the charts to try to fine-tune the timing a little bit.
7:41
Unidentified speaker (speaker_0): Yeah, all really good information for investors. And I know that's exactly what you do on your newsletter, Mark, is you do this kind of teaching talking about where investors should be looking at diving into research on a company before you actually invest. And that's what the Oxford Income Letter is all about. It's a newsletter that Mark puts out every month. There's also a few special reports in
8:01
Unidentified speaker (speaker_0): there that have some of Mark's best. stock picks in different sectors of the market. And you can join that newsletter today by skating the QR code or clicking the link in the description. If you are on the Oxford Income Newsletter, you're going to get all of Mark's knowledge, all of his education, and also those stock picks before anyone else. So sign up for that today. Again, it's a special offer just for our
8:21
Unidentified speaker (speaker_0): viewers. Normally you don't get this kind of access to joining Mark's team. So if you want to join him, and learn a little bit more about him too, make sure to sign up for that Oxford Income Newsletter today. Okay, Mark, I want to get into this list today. And just to preface it, we are not going to be talking about the volatile AI market where we are seeing lots of changes right now,
8:41
Unidentified speaker (speaker_0): especially with NVIDIA. There's a lot of risk in that area. We're going to cover a lot of different kinds of stocks today, and I'm excited about that too.
8:47
Unidentified speaker (speaker_1): Yeah, and these stocks uh are a little bit more uh reciprocative. recession resistant, I think. Um, we have a consumer staples company, a healthcare company. Uh but the first one I want to talk about is Ashland. The ticker is ASH. Not a super well-known stock. They make uh additives and ingredients for food, for
9:07
Unidentified speaker (speaker_1): beauty products, life sciences, other industries. Uh so they're they're really an ingredient company. This stock has been beaten up. They're expected to grow earnings 28 percent this fiscal year, which ends in September of 2027, another 32 percent over the next two years, and it's trading at 18 times 2027
9:27
Unidentified speaker (speaker_1): earnings. So, you know, a a fairly low valuation for the kind of growth that is expected. Now, this growth is is kind of a change. The company had not been doing great uh up until what's
9:38
Unidentified speaker (UNKNOWN): we have a lot of
9:39
Unidentified speaker (speaker_1): now expected going forward. But they what's really interesting here is they are in an activist investor situation. So uh for for your viewers who are not familiar with activist investors, that's when uh usually big hedge funds come in, take a large position in the company and start demanding changes. So in this case,
9:59
Unidentified speaker (speaker_1): they've already added two new board members and the board is now considering strategic alternatives, which often means a sale or a spin-off of some part of the company. And just to give you an example of perhaps roughly where uh the stock could trade, so uh a competitor called
10:18
Unidentified speaker (speaker_1): Selenys had a materials business sort of similar to Ashland. It's not exactly apples to apples, but you know, same general uh sector. And they sold that business for 13 times EBITDA earning before interest taxes, depreciation, and amortization. So if you applied that same multiple to this fiscal year's
10:38
Unidentified speaker (speaker_1): guidance for Ashland, that would come out to $118 a share. And the stock is currently at 76. Now I I don't expect them to get $118. That's you know a a 50% premium and these kinds of companies. aren't going to go for a 50% premium. But it does show you that that there's real opportunity here if they were to sell the
10:58
Unidentified speaker (speaker_1): business, which again, the activists, you know, they want something to happen. They're they're trying to shake things up and and either get this company sold, spin out some businesses, or perhaps just these two new board members will really start to improve things in a dramatic way. So the business is is expected to
11:14
Unidentified speaker (UNKNOWN): be able to do that.
11:15
Unidentified speaker (speaker_1): start growing. And you have these activist investors that are also trying to make things happen on a shorter term basis.
11:23
Unidentified speaker (speaker_0): So interesting. A lot to to dive into there in what you just said. Uh some of what I hear, Mark, sounds like potential risk. Do you think that there is a risk in this one with all of those potential changes? If it's going gonna to be a potential sale, if they've got new transition and in leadership, um uh maybe even changing their business model a little bit by by the sounds of it. Could all of that spell
11:43
Unidentified speaker (speaker_0): risk or does it spell opportunity, or can it be a little bit of both?
11:46
Unidentified speaker (speaker_1): Oh, it it certainly could be both. And and speaking of risk, one thing to point out is that 11% of the float is sold short. You know, typically, so when when you look at at short interest, there's two ways to think about it. One is shorts tend to be pretty smart investors. and they do their homework. So when people get short, there's usually a
12:06
Unidentified speaker (speaker_1): good reason. On the other hand, they're not always right. And when you have a large chunk of stock sold short, that can create what's known as a short squeeze. When a stock starts to rise and you have all these people betting the wrong way, they then have to cover their shorts, otherwise they're, you know, they're taking on big losses. And
12:26
Unidentified speaker (speaker_1): to cover their shorts, that means they have to buy stock. And so when you have a large percent of the float sold short, the potential for a short squeeze with this kind of artificial demand, if the stock starts rising, you get even more buying action because the shorts are covering their positions. That can lead to a short squeeze, which can push a stock sharply higher. So
12:47
Unidentified speaker (speaker_1): seeing a a high short interest is kind of a double-edged sword. You want to be a little bit careful because again, the shorts tend to know what they're talking about. They tend to have good reasons for being short. On the other hand, when it goes against them, it can go against them in a big way and it can happen quickly. So
13:06
Unidentified speaker (speaker_1): I when I was an analyst at a very contrarian research shop, one of the things that we were trained to look for for uh buy recommendations
13:15
Unidentified speaker (speaker_1): were companies with heavy short interest. And if we could find a reason why we believed the shorts were wrong, uh that was very often an excellent opportunity for uh for very quick uh share price appreciation.
13:29
Unidentified speaker (speaker_0): Yeah, I know. I love that I love that about you, Mark, is that you have that specific analyst background too. So you know what to look for and what that can mean sometimes about a company. I want to go back to the valuation because that's kind of the the thesis of this video is talking about these are bargain picks for you. What makes this a a bargain buy and is it is valuation a part of that or is it more of that story you dove into
13:49
Unidentified speaker (speaker_0): right away of the the story behind the scenes of kind of a company in transition?
13:53
Unidentified speaker (speaker_1): The reason I think the valuation is low is because the company is in transition. Uh as I said it's trading at 18 times earnings, but they're expected to grow earnings 28%. So you know, typically if if you can get a price earnings to growth ratio at one or less, which this is because it's 18 times earnings and 28 times uh 28%
14:14
Unidentified speaker (speaker_1): expected earnings growth. So if you can get that that PEG ratio at one or less, typically, I mean every sector's a little different, but typically that's a bargain. So this is this looks very inexpensive to me uh from a price-earnings growth uh ratio. Um so uh that's certainly uh
14:34
Unidentified speaker (speaker_1): what really caught my eye here. The reason it's trading at a bargain valuation is because the company had been struggling for a number of years and has not proven that it has turned things around yet. Again, it's expected to, but it hasn't proven that yet. I suppose once they start reporting out quarter. quarters in 2027, if those numbers are good, uh
14:54
Unidentified speaker (speaker_1): you'll see that valuation increase. All
14:56
Unidentified speaker (speaker_0): right. I'm real a good first company to look at. I want to move on to the next stock that's on your list of where to find value in the market right now. What's the second stock that you're recommending?
15:05
Unidentified speaker (speaker_1): So the second one, and this this one is somewhat uh resist recession resistant, which I always like. Uh Central Garden and Pet Company, uh ticker symbol is C E. C-E-N-T-A. Call this almost a small cap because it's a $2.6 billion market cap. Uh typically the cutoff for a market cap is $2 billion, but this is this is pretty close. Um
15:25
Unidentified speaker (speaker_1): this is trading at just 14 times forward earnings, where earnings are expected to grow 27% over over the next four years. It's trading below the sector median of sixteen 16 times uh forward earnings. So it's trading uh, you know, below the uh the market median, the sector median. Uh price to
15:44
Unidentified speaker (speaker_1): sales on a trailing and forward basis is right at one. Uh that's typically kind of the line in the sand for what's considered a bargain. Anything at one or less on price to sales is considered cheap. Also a little bit below the sector median.
15:59
Unidentified speaker (UNKNOWN): Uh
15:59
Unidentified speaker (speaker_1): price to cash flow is a little bit below eight. and well below the 10.7 sector median. And also, very general terms, anything below 10 times cash flow is considered inexpensive. At the same time, this is a cash flow positive company, very cash flow positive. It generates $300 million a
16:19
Unidentified speaker (speaker_1): year in free cash flow, is a very healthy balance sheet. Does have some debt, but debt has been at the same level for years. It's growing the amount of cash it has. And then I think this is really interesting. You know, earlier we were talking about from a technical perspective. If you look at the chart, it's really been trading sideways for um about
16:40
Unidentified speaker (speaker_1): five years, six years. And uh if if you if you pull up that chart,
16:44
Unidentified speaker (UNKNOWN): you know,
16:44
Unidentified speaker (speaker_1): it hit a high in 2021, uh just below $45 and has not been able to get back there. It looks like it's it's about to try. And if it can get through $45, I think this is easily a $60 stock within, let's say, 12 months. So you have a very, very low
17:04
Unidentified speaker (UNKNOWN): uh,
17:04
Unidentified speaker (speaker_1): you know, valuation with a stock that looks like it's trying to start to get going. And if it does, it could, it could move quickly.
17:11
Unidentified speaker (speaker_0): Yeah, this is an interesting one. It has absolutely shown up on my show before, but not for over a year. I think it's been almost two years since I heard this name pop up. I was talking to another value investor like yourself that's always looking for solid companies. And so uh it makes sense that this this stock shows up again with you for sure. I think looking back historically is a great way to
17:31
Unidentified speaker (speaker_0): analyze this company and looking for that new breakout. I think the twenty 2021 twenty one influx uh and rise in the stock makes sense. because everybody got a puppy during COVID. During the lockdown, everyone got a new pet. And so I think that that surge in that 2020, 2021 season makes a lot of sense based on what was happening in
17:51
Unidentified speaker (speaker_0): the world. And so when you say that you started this talking about a little bit of a recession proof company, I'm I'm curious with pet care, with any any company that's tied to that, is that really it really? a recession proof industry or is that an area in difficult economic times where people might tighten their personal belts and spend a little bit less, that sort of
18:11
Unidentified speaker (speaker_0): thing? Or is what Central Pet offers so essential to whether it's farmers or pet owners, that sort of thing, that they're kind of that recession proof uh business?
18:21
Unidentified speaker (speaker_1): Yeah. So I I would use the term recession resistant versus, you know, truly recession proof. But you know, with you know, we've seen just this very strong trend over the past decade, maybe even longer, of almost the humanization of our pets, where people truly believe that they are part of their families. You know,
18:41
Unidentified speaker (speaker_1): it's very different, I think, than from when I was a kid. And and certainly people loved their their dogs and their cats and their pets back then, but I don't think anybody really used the term family back then, whereas now they really do. I mean, every plane you get on, everybody's got their dogs and cats. So it it it's
19:00
Unidentified speaker (speaker_1): I have a hard time picturing in a recession people just, you know, kind of giving up their dogs and cats because they're too expensive. Obviously that, you know, there may be some that have to, but for the most part,
19:11
Unidentified speaker (UNKNOWN): uh it
19:12
Unidentified speaker (speaker_1): it's it's a member of their family, and and I don't I don't expect that they're going to give it up. They may downgrade, let's say, the dog food instead of the super expensive organic, you know, chef-prepared dog food. They may go back to uh to more traditional food for the dogs. But uh I I do think that people will continue to love their pets, to to, you
19:31
Unidentified speaker (speaker_1): know, want to keep them happy and healthy as long as they can. And especially during tough times, you know, when perhaps you're not going out. as much, then having that time with the dog and uh and getting some enjoyment uh at home will be even more important.
19:46
Unidentified speaker (speaker_0): Yeah, I know I shared this with my viewers, or I'm a new puppy parent right now. Uh we've had a puppy for about a month and it it's a
19:52
Unidentified speaker (UNKNOWN): lot of
19:52
Unidentified speaker (speaker_0): work. But yes, definitely a family member for sure. So interesting company to talk about. More on the the fundamentals of the company and the the price action in the chart. Why would a company like this that does have that strong potential, like you said, be be kind of trading sideways for so long? For five years is a long time to kind of stay within a similar range. What
20:12
Unidentified speaker (speaker_0): would cause a breakout now? What what's changing that that shift?
20:16
Unidentified speaker (speaker_1): So it can be a number of things. I mean, you could see the company starting to uh you know improve their numbers, or uh what very often happens and and and this is, I think, one of the benefits of looking at the charts, is very often the price starts to move before the fundamentals do. So
20:36
Unidentified speaker (speaker_1): investors that are in the know, whether that is insiders buying the stock or hedge funds that are really doing their homework and are having conversations with management, You know, they're buying the stock in anticipation of things that
20:50
Unidentified speaker (UNKNOWN): are not.
20:51
Unidentified speaker (speaker_1): turning around fundamentally. You know, so often, whether we're talking broad markets or individual stocks, you'll often see price uh, you know, uh ahead of the changes in the move. I mean, just even looking at NVIDIA, uh, NVIDIA stock has been falling for several weeks before you know the scandal
21:10
Unidentified speaker (speaker_1): broke with uh the CEO. So I'm not saying that that was the reason it fell. but it it's not unusual that the price precedes uh, you know, su uh news or or or fundamentals.
21:23
Unidentified speaker (speaker_0): That was a really good answer to a really hard question, Mark. Thank you so much for diving into that. I again I love having you on the show because you are such a calm and very wise teacher for investors who are especially just kind of learning where to find value in this market, especially those who maybe have had their portfolios hit really hard in the last few weeks of volatility in the market, of
21:43
Unidentified speaker (speaker_0): chasing the dips that are out there. This is a different way to look at investing. And I think that you can learn more by joining Mark's Oxford Income Newsletter. Again, he sends out newsletters every month. He interacts directly with his subscribers at the Oxford Income Newsletter. So this is a great way to kind of reach out to Mark directly and learn from him and also get some of his. best
22:03
Unidentified speaker (speaker_0): stock picks in the market, this different way of looking at investing and finding real value, especially through volatile times. So scan the QR code, click the link in the description. Again, you have special access to join Mark's newsletter through that link in the description. All right, Mark, we have one more stock to cover today. What's the third area that you are finding some value in the market right
22:23
Unidentified speaker (speaker_0): now? Aaron
22:23
Unidentified speaker (UNKNOWN): Ross Powell All
22:24
Unidentified speaker (speaker_1): right. So this one I would call somewhat recession proof, and that's HCA Healthcare, ticker symbol HCA. They are the largest hospital network in the United States. So, you know, good times, bad times, if you need your appendix out, uh you're probably gonna get it. Right. So I do like, you know, hospitals for that reason.
22:44
Unidentified speaker (speaker_1): They are um it's the largest in the in the U.S., but they have a pretty strong concentration in tech. Texas and Florida, uh, where you know the demographics are very, very strong, a lot of people moving to both states, Florida, uh, you know, certainly uh an older population. So what we know about older people is they
23:04
Unidentified speaker (speaker_1): need more health care. Uh so uh it's certainly a great market for a hospital chain to be in. Uh earnings are projected to more than triple over the next 10 years, yet it's only trading. at a 17
23:17
Unidentified speaker (speaker_1): PE ratio, both trailing and forward, and which is below the sector median of 20. So I think a very, very good valuation for the growth that it is expected to experience. And then you have politics. So Democrats, as we know, know, you know, are controlling the Senate and the House.
23:37
Unidentified speaker (speaker_1): They're going to be fighting hard to roll. back cuts to Medicaid. Any uh rollback of those cuts will certainly be positive for hospitals. Then looking out past 2028, if the Democrats maintain uh control of Congress and a Democrat gets elected, then suddenly Medicare for All
23:57
Unidentified speaker (speaker_1): is on the table, and that would be a boom for health healthcare care providers like hospitals.
24:04
Unidentified speaker (speaker_1): So I I think there's there's a lot to like here on the story. And then if you look at the chart, this is one of the strongest long-term charts you will ever see, perhaps other than Nvidia. I mean this stock is up 30x in about 15 years. And so it's down from its all-time highs, but not that much. I mean
24:24
Unidentified speaker (speaker_1): we're it we're probably about 10% from all time all-time highs. So it's not that this is a stock that's been absolutely creamed that you're scooping up at bargain basement levels. No, this is just a stock that has been just a fantastic long-term performer that's trading at a at a real good valuation compared to the huge growth it's expecting.
24:44
Unidentified speaker (speaker_1): And then as of this moment, you have political tailwinds that obviously could change at at any time, but at least as of right now, it's uh it's it's in the company's favor. And like I said, it's it's somewhat recession proof in that you know people need their health care and they're they're gonna go to the hospital when they need to, whether
25:04
Unidentified speaker (speaker_1): uh you know GDP is is booming or contracting. Yeah,
25:07
Unidentified speaker (speaker_0): the long-term chart really stands out, Mark. I'm glad that you pointed that out because it's incredibly strong, like you said. Also, some of the political issues.
25:15
Unidentified speaker (speaker_0): and points for this company are so interesting to think about and could be momentum drivers or maybe volatility drivers. I think that that anytime you have politics involved in a company business model, I do think that it can lead to just volatility because it's unpredictable. Um, and that's part of it for sure. But let's look at the earnings and the valuation for this
25:35
Unidentified speaker (speaker_0): company too. And I know you mentioned it already, but just looking at their last earnings report, incredibly solid. Do you think that we can continue to see that same kind of quarterly growth for this company? And will that be enough to move the momentum forward for this stock? Or are all those other factors, the political issues hanging overhead, the other things, potential
25:55
Unidentified speaker (speaker_0): holdbacks for this stock to continue to grow?
25:58
Unidentified speaker (speaker_1): For 2026 and 2027, earnings estimates are for single-digit growth, acceleration. accelerating to double digits every year from 2028 to 2035, including uh getting up into the the 20s as you get to 2034, 2035. Now, obviously that's a long way off. Those those numbers are going to change over time,
26:18
Unidentified speaker (speaker_1): but uh it does show you the um the the projections uh and what Wall Street is expecting from this company as far as growth you know because of its business model, because it's the largest hospital chain in the country. And so it you know it certainly has uh all the advantages of that scale, whether you're talking
26:38
Unidentified speaker (speaker_1): about cost control, whether you're talking about dominating certain markets. So there's just a lot to like here for the long term.
26:47
Unidentified speaker (speaker_1): Short Short-term. term, if you and again, if you look at the chart, the that long term long-term chart is great, but there have been some
26:53
Unidentified speaker (speaker_1): significant uh dips along the way. So, you know, this is a stock that I like from a valuation perspective to put in your portfolio and be more of a set it and forget it type stock that, you know, the kind of thing that you're going to look back at five, ten years, and I think it's going gonna to do really, really well because of its business model and
27:13
Unidentified speaker (speaker_1): you're buying it at a at a very good valuation. But again, you you mentioned politics, anything could happen in 2028, a Republican is re-elected to the White House or Congress shifts. Uh that could put some pressure on the story, perhaps on expected earnings going forward. Uh but also, you know,
27:33
Unidentified speaker (speaker_1): healthcare policy is uh it's like you know, turning around a a cruise ship. It takes a while. It's not uh it's not an easy pivot. So you know, I I I think these things kind of these these kind of stories and these tailwinds, at least right now, probably have some legs to last for a few years.
27:52
Unidentified speaker (speaker_0): Yeah, absolutely. Like you said, anything can happen. We saw that this week with NVIDIA. Uh a week ago, this wasn't even on anyone's horizon. And then a week later, uh one of the largest you know, most important CEOs in the nation is now out. So, like you said, anything can happen. It's a different comparison, but I think it's important for investors to keep that in mind too.
28:12
Unidentified speaker (speaker_0): Mark, I love this conversation today, especially given everything that's happening this week and last week in the market. It's good to also take a look and not forget about these solid companies that have true momentum going, have really strong fundamental. fundamentals, and are real actual value plays and value buys for investors to consider. Thank you again, Mark,
28:32
Unidentified speaker (speaker_0): for coming on the show and giving us a little diversity in the stocks that we're talking about this week. If you want to hear more from Mark, we recently had him on the show too, and he talked a lot about these same kind of value stocks where you can find long long-term term growth over time. You could watch that latest interview we had with Mark right here and get more stock ideas. from him too.
This page was produced automatically: the audio was transcribed with nvidia/parakeet-tdt-0.6b-v3+sortformer-v2.1 and interpreted by Qwen3.6-35B-A3B-UD-IQ3_S.gguf. Transcription and interpretation can contain errors; always confirm against the original episode. Nothing here is investment advice.

More from MarketBeat | Stock Market News & Analysis

MarketBeat | Stock Market News & Analysis

If You're an NVIDIA Shareholder... Get Ready! (Live Earnings Reaction)

Episode discussion: NVIDIA Q3 Earnings Beat on Vera Rubin Ramp; CEO Huang Resigns

Speakers’ claims: Speakers analyze NVIDIA's Q3 FY2027 earnings, highlighting record revenue of $116 billion and the rapid ramp of the Vera Rubin platform. The episode covers the resignation of CEO Jensen Huang due to personal conduct issues and the appointment of Interim CEO Colette Kress. Analysts discuss the strong guidance, including a 75% year-over-year revenue growth forecast for fiscal 2028, and the acquisition of Hugging Face. The hosts also examine the health of the AI ecosystem, noting positive reactions from NeoCloud stocks and validating the long-term demand for AI infrastructure.

NVIDIAAI InfrastructureEarnings
1h 44m0 assets26 claims to verify
MarketBeat | Stock Market News & Analysis

Stocks Are Moving Fast, Here's What You Need to Know Before Tuesday!

Episode discussion: Speakers analyze AI sector volatility, NVIDIA earnings preview, and specific stock opportunities in Marvell, Western Digital, and Amazon.

Speakers’ claims: Hosts discuss market volatility driven by the 'Jensen Huang Affair' and anticipate NVIDIA's earnings as a key catalyst. They analyze AI stock pullbacks, arguing fundamentals remain strong despite short-term fear. Specific stock discussions include Marvell's acquisition of Lumentum, Western Digital's valuation, and Amazon's stake in Anthropic. The episode also covers technicals for Kohu and Palantir, fundamentals for BBAI, and defense stocks like Kratos and Ondas.

AI HardwareNVIDIAMarket Volatility
1h 8m4 assets23 claims to verify
All insights